CA15-3 change after 12 months (≤1 vs. ≥1) | 3.167 (0.9223 - 10.88) | 0.067 | 2.207 (0.6413 - 7.599) | 0.209 |
CA15-3 normal or abnormal at bone metastasis onset | 0.931 (0.3244 - 2.672) | 0.8943 |
|
|
CEA change after 6 months (≤1 vs. ≥1) | 1.687 (0.4866 - 5.846) | 0.4098 |
|
|
CEA change after 12 months (≤1 vs. ≥1) | 2.377 (0.7183 - 7.869) | 0.1562 |
|
|
CEA normal or abnormal at bone metastasis onset | 1.023 (0.3407 - 3.071) | 0.9679 |
|
|
With hormone therapy or without hormone therapy | 1.023 (0.3407 - 3.071) | 0.9679 |
|
|
With anticancer drug or without anticancer drug. | 1.909 (0.5378 - 6.775) | 0.3172 |
|
|